Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[ash111]

KTOV has a billion dollar drug.A very Solid day on tase today(+13%).cant wait for updates.float is tiny and insiders buying nonstop.holding for $30 at least.

Rodman & Renshaw ,believes its leading product, KIT-302, has the potential to reach blockbuster status in the US alone. even on $50 cap will be still very reasonable about $185m. We are talking about the same Celebrex ($1.8B sales/year) but without its risks.The company has no debt, no need to raise cash due P3 declared final and target was fully achieved.Celebrex has $1.8B in rev every year,if we take only 10% of their market share alone,on 70% profit margin will brings us to $130 net income per year.
8 times market cap($15m current cap) might be equal to only one year net income. calculate PV and you ended up with a present value of $1B+. a major pharma can plop down $200m- $300m on a buyout for a billion dollar risk reward as well even before the drug hit the market (2017),imo